IAF News and Press, Aberdeen Australia Equity Fund Inc From 09/05/25

2025-09-05 07:48:00 ET Fund performance The Fund returned 9.24% over the review period, outperforming the benchmark ASX 200 Index’s return of 8.85%. The Fund outperformed its benchmark over the review period. Strong stock selection in healthcare and financials more than offse...

2025-07-06 18:46:23 ET Abrdn Australia Equity Fund Inc (IAF) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 0.50%. The average open to low on the day of earnings was -0.97%. The average...

2025-07-06 18:41:22 ET Abrdn Australia Equity Fund Inc (IAF) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in IAF stock price following earnings has averaged ±0.63% , with a median of 0...

ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS PR Newswire PHILADELPHIA , June 30, 2025 /PRNewswire/ -- The Aberdeen Investments U.S. Closed-End Funds (NYSE: ASGI, HQH, HQL, IFN, THQ), (NYSE American: IAF)  (the "Funds" ...

2025-06-03 09:00:00 ET Summary After a very strong 2024, it was a challenging start to the new year with the Fund contracting by 6.58% in US dollar terms, underperforming the benchmark by 363 basis points in NAV terms. Some of the key detractors this quarter had been among the bes...

2025-06-03 08:20:00 ET Summary The equity portion of the Fund rose (gross of fees) but underperformed its benchmark over the quarter. The top three detractors over the quarter were Novo Nordisk, uniQure and Teva Pharmaceutical Industries. The top three positive contributors we...

2025-06-03 08:05:00 ET Summary The abrdn Ultra Short Municipal Income Fund returned 0.75% for the first quarter, underperforming the 1.05% return of its benchmark, the Bloomberg Barclays Municipal Bond 1 Year (1-2) Index. During the quarter, the Fund’s exposures to other re...

2025-06-03 08:00:00 ET Summary The Fund fell (gross of fees) but outperformed the Russell 2000 Index. At the stock level, Corcept Therapeutics’ shares outperformed after the company’s key drug achieved positive study results for the treatment of a new condition, sign...

2025-06-03 07:20:00 ET Summary The abrdn Total Dynamic Dividend Fund outperformed its benchmark over the three-month period ending 30 April 2025 due to stock selection and, to a lesser extent, sector allocation. Global equity markets ended lower over the period, weighed down by mo...

2025-06-03 07:00:00 ET Summary The abrdn Short Duration High Yield Municipal Fund returned 0.47% for the first quarter, underperforming the 0.78% return of its benchmark, the S&P Municipal Bond Short Intermediate Index. During the quarter, the Fund’s exposure to student...